ArticleJournal of global health2026
Strengthening public health programmes and the antivenom ecosystem: strategic policy priorities to combat envenomation by animal bites and stings in Latin America and the Caribbean.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Envenomation by snakes, scorpions, spiders, and caterpillars remains a major but unevenly addressed public health challenge in Latin America and the Caribbean (LAC). Environmental change, urbanisation, and ecological disruption are changing the distribution of medically important species, while persistent gaps in surveillance, clinical management, and antivenom availability limit prevention and care. In this study, we analysed epidemiological trends, health system capacity, and the regional antivenom ecosystem to inform strategic public health priorities. Methods: We analysed secondary data from regional surveys coordinated by Pan American Health Organization networks for the period 2019-2024. We used negative binomial regression models to assess temporal trends in total cases and deaths from four major envenomations and to generate projections up to 2030. We used spatial analyses to examine heterogeneity in incidence, mortality, and case-fatality rates, and evaluated antivenom production, procurement, and use with indicators standardised to epidemiological burden. We complemented the quantitative findings with qualitative content analysis of regional and meeting reports. Results: The incidence of all envenomations showed an increasing trend over time, with particularly marked increases in spider bites and caterpillar contacts. We observed spatial heterogeneity across countries. Overall mortality remained low for most envenomations, while the case-fatality rate for spider envenomation was projected to increase by 2030 if the observed trends continued. We identified weaknesses in surveillance quality, risk mapping, clinical preparedness, and follow-up of sequelae. We also identified mismatches between antivenom production, procurement, and therapeutic use, varying by envenomation type. Regional initiatives have strengthened coordination but have not fully resolved inequities in access and preparedness. Conclusions: Envenomation in LAC remains an expanding and evolving public health challenge requiring coordinated, forward-looking responses. While acknowledging limitations in data quality and the need for longer-term evidence, our findings provide a system-level analysis and generate scientifically and policy-relevant evidence, supporting a targeted action framework to advance progress toward the World Health Organization 2030 targets for reducing envenomation-related morbidity and mortality.
Indexed as
Identifiers
42852600What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.